| Literature DB >> 33923887 |
Carl Christoph Goetzke1,2,3, Frédéric Ebstein4, Tilmann Kallinich1,2,3,5.
Abstract
The ubiquitin-proteasome system (UPS) is involved in multiple cellular functions including the regulation of protein homeostasis, major histocompatibility (MHC) class I antigen processing, cell cycle proliferation and signaling. In humans, proteasome loss-of-function mutations result in autoinflammation dominated by a prominent type I interferon (IFN) gene signature. These genomic alterations typically cause the development of proteasome-associated autoinflammatory syndromes (PRAAS) by impairing proteasome activity and perturbing protein homeostasis. However, an abnormal increased proteasomal activity can also be found in other human inflammatory diseases. In this review, we cast a light on the different clinical aspects of proteasomal activity in human disease and summarize the currently studied therapeutic approaches.Entities:
Keywords: autoimmune; autoinflammation; inflammation; proteasome; proteasome-associated autoinflammatory syndrome
Year: 2021 PMID: 33923887 DOI: 10.3390/jcm10081783
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241